Abstract
Aripiprazole is the first next generation atypical antypsychotic drug destined for treatment of schizophrenia. Originally discovered by Otsuka Pharmaceutical Co., the compound was jointly developed by Otsuka and Bristol Myers Squibb and was first marketed in the USA in 2002 under the trade name Abilify. The value of sales of Abilify preparations in the world in the years 2009 and 2010 was 6522.94 and 6742.51 million USD, which provided the aripiprazole, manufactured by Otsuka company, third and second place respectively in the Top50 list of drugs acting on the central nervous system. This review presents the currently known methods of aripiprazole manufacturing, both from the point of view of its synthesis and the possibility of formation of polymorphs, solvates, salts, co-crystals and amorphous solids.
Keywords: Amorphous solids, antypsychotic drugs, aripiprazole, arylpiperazines, co-crystals, polymorphs, salts, schizophrenia, solvates.
Mini-Reviews in Organic Chemistry
Title:Recent Approaches to the Synthesis of Aripiprazole – A New Generation Antypsychotic Drug
Volume: 9 Issue: 4
Author(s): Piotr Kowalski, Jolanta Jaskowska and Zbigniew Majka
Affiliation:
Keywords: Amorphous solids, antypsychotic drugs, aripiprazole, arylpiperazines, co-crystals, polymorphs, salts, schizophrenia, solvates.
Abstract: Aripiprazole is the first next generation atypical antypsychotic drug destined for treatment of schizophrenia. Originally discovered by Otsuka Pharmaceutical Co., the compound was jointly developed by Otsuka and Bristol Myers Squibb and was first marketed in the USA in 2002 under the trade name Abilify. The value of sales of Abilify preparations in the world in the years 2009 and 2010 was 6522.94 and 6742.51 million USD, which provided the aripiprazole, manufactured by Otsuka company, third and second place respectively in the Top50 list of drugs acting on the central nervous system. This review presents the currently known methods of aripiprazole manufacturing, both from the point of view of its synthesis and the possibility of formation of polymorphs, solvates, salts, co-crystals and amorphous solids.
Export Options
About this article
Cite this article as:
Kowalski Piotr, Jaskowska Jolanta and Majka Zbigniew, Recent Approaches to the Synthesis of Aripiprazole – A New Generation Antypsychotic Drug, Mini-Reviews in Organic Chemistry 2012; 9 (4) . https://dx.doi.org/10.2174/157019312804699447
DOI https://dx.doi.org/10.2174/157019312804699447 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hold Onto Your Hat! - Handling the Roller Coaster Emotions of the College Application Process
Adolescent Psychiatry Lipid Nanoparticles for the Delivery of Active Natural Medicines
Current Pharmaceutical Design Spirulina in Health Care Management
Current Pharmaceutical Biotechnology Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential
Anti-Cancer Agents in Medicinal Chemistry Reasons for Physicians Choice of Medication in Medication-Naive Patients with ADHD: Baseline Data from the COMPLY Observational Study
Current Drug Therapy Pharmacological Properties of Glutamatergic Drugs Targeting NMDA Receptors and their Application in Major Depression
Current Pharmaceutical Design Knockdown of H19 Enhances Differentiation Capacity to Epidermis of Parthenogenetic Embryonic Stem Cells
Current Molecular Medicine Histone Acetylation Regulates Natriuretic Peptides and Neprilysin Gene Expressions in Diabetic Cardiomyopathy and Nephropathy
Current Molecular Pharmacology Possible Drug Candidates for Alzheimers Disease Deduced from Studying their Binding Interactions with α7 Nicotinic Acetylcholine Receptor
Medicinal Chemistry Pharmacokinetic Properties and In Silico ADME Modeling in Drug Discovery
Medicinal Chemistry Medicinal Chemistry of Adenosine A2A Receptor Agonists
Current Topics in Medicinal Chemistry Management of Glioblastoma Multiforme by Phytochemicals: Applications of Nanoparticle-Based Targeted Drug Delivery System
Current Drug Targets Antibodies As Promising Novel Neuroprotective Agents in the Central Nervous System Injuries
Central Nervous System Agents in Medicinal Chemistry Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Upregulation of Connexin-43 is Critical for Irradiation-induced Neuroinflammation
CNS & Neurological Disorders - Drug Targets Stem Cell-Based Immunomodulation in Type 1 Diabetes: Beyond the Regenerative Approach
Current Pharmaceutical Design TNF-α Polymorphisms and Maternal Depression in a Mexican Mestizo Population
CNS & Neurological Disorders - Drug Targets 5 Hz Repetitive Transcranial Magnetic Stimulation with Maximum Voluntary Muscle Contraction Facilitates Cerebral Cortex Excitability of Normal Subjects
CNS & Neurological Disorders - Drug Targets Role of Cardiolipin in Mitochondrial Diseases and Apoptosis
Current Medicinal Chemistry Common Molecular Targets for Bioactive Food Components and Drugs
Current Pediatric Reviews